Patents Represented by Attorney, Agent or Law Firm Peter C. Lauro
  • Patent number: 6835929
    Abstract: Disclosed herein is a mass spectrometer having an atmospheric pressure photoionization (APPI) source that comprises a discharge lamp coupled to a nebulizer, wherein the nebulizer is at, or near, atmospheric pressure. The discharge lamp curves around the vapor path and this coaxial design offers significant advantages over the prior art such as increased photon flux resulting in increased photoionization efficiency. One of the significant benefits of an increase in photon flux is that absorption of the UV radiation by solvents such as acetonitrile is minimized. The APPI source described herein also facilitates a larger photoionization interaction zone with effluent from the nebulizer, which may be heated. Additionally, no dopant is required in this coaxial APPI system.
    Type: Grant
    Filed: January 27, 2003
    Date of Patent: December 28, 2004
    Assignee: Waters Investments Limited
    Inventor: Jeffrey W. Finch
  • Patent number: 6790361
    Abstract: A method and device for increasing the loading capacity of a chromatography column through dilution of a mobile phase at the head of the column. A strong mobile phase is provided for dissolving a sample. A sample is injected into the strong mobile phase, and subsequently diluted with a weak mobile phase. The resulting sample-containing weak mobile phase is passed through a chromatography column for retention and separation of the components of the sample.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: September 14, 2004
    Assignee: Waters Corporation
    Inventors: Thomas E. Wheat, Charles H. Phoebe, Mark K. Baynham, Uwe Dieter Neue, Raymond P. Fisk, Richard C. Turner
  • Patent number: 6716885
    Abstract: A storage-stable aerated gel composition comprising 30 to 97% by weight of water, 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralized carboxyvinyl polymer and 2 to 5% by weight of a fine particulate hydrophobic silicone-treated silica having a surface area of from 80 to 300 m2/g. The composition is in the form of fine particles of an aqueous gel containing the water and the gelling agent, the surface of which particles are coated with a coating of the finely divided particulate hydrophobic silica. The gel composition is prepared by mixing, under high shear conditions, the water and the fine particulate silica, and then adding to the resulting mixture, the gelling agent and mixing under high shear conditions.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: April 6, 2004
    Assignee: Sorex Limited
    Inventors: Roland Twydell, Lesley Le Quesne
  • Patent number: 6686035
    Abstract: Novel material for chromatographic separations, processes for its preparation, and separations devices containing the chromatographic material. In particular, the disclosure describes porous inorganic/organic hybrid particles having a chromatographically-enhancing pore geometry, which desirably may be surface modified, and that offer more efficient chromatographic separations than that known in the art.
    Type: Grant
    Filed: August 7, 2001
    Date of Patent: February 3, 2004
    Assignee: Waters Investments Limited
    Inventors: Zhiping Jiang, Raymond P. Fisk, John O'Gara, Thomas H. Walter, Kevin D. Wyndham
  • Patent number: 6632795
    Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: October 14, 2003
    Assignee: BASF Aktiengesellschaft
    Inventors: Teresa Barlozzari, Andreas Haupt
  • Patent number: 6607894
    Abstract: This invention relates to methods for assaying the presence and/or risk of endometrial cancer by measurement of levels of matrix metalloproteinase-2 and/or matrix metalloproteinase-9 in uterine washings. The method may be qualitative or quantitative, and is adaptable to large-scale screening and to clinical trials.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: August 19, 2003
    Inventors: Alexander Lopata, Lois A. Salamonsen, Michael A. Quinn
  • Patent number: 6599531
    Abstract: Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising ibuprofen; a narcotic analgesic; colloidal silicon dioxide; a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate; a binder consisting of an akylhydroxy methylcellulose; a starch; and a lubricant.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 29, 2003
    Assignee: Knoll Pharmaceutical Company
    Inventors: Gregory P. Kushla, Jin-Wang Lai, Gerald P. Polli
  • Patent number: 6599703
    Abstract: An iterative and regenerative method for sequencing DNA is described. This method sequences DNA in discrete intervals starting at one end of a double stranded DNA segment. This method overcomes problems inherent in other sequencing methods, including the need for gel resolution of DNA fragments and the generation of artifacts caused by single-stranded DNA secondary structures. A particular advantage of this invention is that it can create offset collections of DNA segments and sequence the segments in parallel to provide continuous sequence information over long intervals. This method is also suitable for automation and multiplex automation to sequence large sets of segments.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: July 29, 2003
    Assignee: University of Iowa Research Foundation
    Inventor: Douglas H. Jones
  • Patent number: 6589960
    Abstract: A method for the preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of hydrogen gas. The method is useful for preparing hydromorphone and hydrocodone compositions having novel impurity profiles. Compositions comprising hydromorphone and hydrocodone are also disclosed.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: July 8, 2003
    Assignee: Abbott Laboratories
    Inventors: William H. Harclerode, Robert Gault, Mark D. Sandison
  • Patent number: 6565861
    Abstract: Provided by the present invention are formulations suitable for application to mammalian eyes which contain a lipid binding protein and a polar lipid, present as a soluble complex in an aqueous electrolyte. The formulations described have shear-thinning (non-Newtonian viscosity) and surface tension properties to natural tears and are therefore useful as artificial tear substitutes for the treatment of dry eyes (e.g. keratoconjunctivitis sicca) and useful in ophthalmic applications in general.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: May 20, 2003
    Assignee: ISIS Innovation Limited
    Inventors: John Michael Tiffany, Beatrix Valeria Macey-Dare
  • Patent number: 6555325
    Abstract: The present invention makes available a rapid, reproducible, robust assay system for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of a cellular protein, e.g., a receptor or ion channel. The subject assay enables rapid screening of large numbers of compounds to identify those which act as an agonist or antagonist to the bioactivity of the cellular protein. In this system, the first cell is treated with a compound, and functional interaction of this compound with a cellular receptor yields a secreted signal. A second cell, bearing a receptor for this secreted signal, makes use of an indicator gene in a signaling pathway coupled to this second receptor. The subject assays include methods of identifying compounds which specifically modulate, for example, heterologous receptors coupled to the pheromone response pathway in yeast.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: April 29, 2003
    Assignee: Cadus Technologies, Inc.
    Inventor: Lambertus J. Oehlen
  • Patent number: 6541672
    Abstract: The invention deals with the derivatives of benzilidine having basic formula as follows (I): wherein X can be cyclohexanone, cyclopentanone, or acetone, while Y and Z can be either electron withdrawing, electron donating or steric group. Y may or may not be the same with Z. Methyl, ethyl, methoxy group or halogen were prefered in the experiment. The benzilidine cyclohexanone, benzilidine cyclopentanone, and benzilidine acetone derivates were found to be novel compounds showing anti-bacterial, antioxidant, and anti-inflammatory activities that enable them to be used for drug.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: April 1, 2003
    Assignee: Faculty of Pharmacy, The University of Gadjah Mada
    Inventors: Sardjiman, Mochammad Samhoedi Reksohadiprodjo, Henk Timmerman
  • Patent number: 6528167
    Abstract: A material for chromatographic separations, processes for its preparation, and separation devices containing the chromatographic material. In particular, porous inorganic/organic hybrid materials are provided with a decreased concentration of surface organic groups. These particles may be surface modified and have enhanced stability at low pH.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: March 4, 2003
    Assignee: Waters Investments Limited
    Inventor: John E. O'Gara
  • Patent number: 6511971
    Abstract: Phthalocyanine compounds of the formulas I and II: wherein X1-8 are each halogen and R1-8 are each independently halogen or an anti-stacking moiety; and [MxLySz]Cw  (II) wherein M is a metal, L is an anion of a phthalocyanine compound of formula I as defined above, S is an organic or inorganic ligand, C is a counterion, x and y are numbers greater than zero, and z and w are numbers zero or greater, are disclosed. Pharmaceutical compositions comprising the compounds and methods of using the compounds, for example for treatment of cancer, are also disclosed.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: January 28, 2003
    Assignee: Brown University Research Foundation
    Inventor: Sergiu M. Gorun
  • Patent number: 6512117
    Abstract: A method for the preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of hydrogen gas. The method is useful for preparing hydromorphone and hydrocodone compositions having novel impurity profiles. Compositions comprising hydromorphone and hydrocodone are also disclosed.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: January 28, 2003
    Assignee: Abbott Laboratories
    Inventors: William H. Harclerode, Robert Gault, Mark D. Sandison
  • Patent number: 6511592
    Abstract: A sensor for pentachlorophenol comprises a sensor electrode carrying a pentachlorophenol hydroxylase, and a counter electrode. An assay method comprises maintaining a potential difference between the electrodes and observing a current associated with enzyme-catalyzed oxidation of the pentachlorophenol.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: January 28, 2003
    Assignee: ISIS Innovation Limited
    Inventors: Hugh Allen Oliver Hill, Luet-Lok Wong, Weihong Xie, Jonathan Peter Jones
  • Patent number: 6492526
    Abstract: Organometallic complexes comprising a divalent lanthanide metal cation complexed with from one to three polydentate ligands which preferably contain one or more pyrazolyl groups, such as trispyrazolylborate anions, are useful in light emitting devices e.g., in electroluminescent flat panel displays. In the complexes, several classes of which are novel, the lanthanide metal is preferably Eu since the Eu complexes have the ability to exhibit bright electroluminescence ranging from yellow to orange to blue.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: December 10, 2002
    Assignee: Isis Innovation Limited
    Inventors: Victor Christou, Oleg Victorovitch Salata, Christopher Shipley
  • Patent number: 6479538
    Abstract: Novel cyclic ether vitamin D3 compounds having a cyclic ether side chain are disclosed. These compounds were first identified as metabolites of 3-epi vitamin D3 produced via a tissue-specific metabolic pathway which catalyzes the formation of a cyclic ether structure. Also disclosed are 1&agr;(OH) 3-epi vitamin D3 compounds, which are produced via the epimerization of a 3-&bgr;-hydroxyl group of 1&agr;(OH) vitamin D3 precursor in vivo. The vitamin D3 compounds of the present invention can be used as substitutes for natural and synthetic vitamin D3 compounds.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: November 12, 2002
    Assignee: Women and Infants Hospital
    Inventor: Satayanarayana G. Reddy
  • Patent number: 6458765
    Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L  (I), and acid salts thereof, wherein A, B, D, E, F, G and K are &agr;-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: October 1, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Bernd Janssen, Teresa Barlozzari, Andreas Haupt, Thomas Zierke, Andreas Kling
  • Patent number: 6458842
    Abstract: There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; which has utility in the treatment of disorders associated with an impairment of the thyroid hormone function in animals including human beings. The liquid composition may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: October 1, 2002
    Assignee: Knoll Aktiengesellschaft
    Inventors: Jeffrey Dickinson, Karrar Ahmad Khan, John Neville Hague, Alan Smith